Off Patent
December 2027

Lastacaft

alcaftadine

Abbvie Inc

Solution/drops (ophthalmic) · NDA 022134

Last listed protection ends
December 23, 2027

The FDA lists 2 patents for Lastacaft, and this is the day the last one ends. It is not the date a generic goes on sale.

Patents and exclusivities

  1. Patent 10,617,695
    Claims the drug product and a use (U-3267)
  2. Patent 8,664,215
    Claims a use (U-3267)